Dermatology News

Deucravacitinib is superior to placebo for improving response across all domains of minimal disease activity criteria in patients with psoriatic arthritis at 16 weeks, according to data published in Rheumatology.

The CMS finalized cuts to the 2025 physician fee schedule for the fifth year in a row, prompting an urgent call-to-action from the American Academy of Dermatology. HHS, through the CMS, announced the finalization of the 2025 Medicare Physician Fee Schedule.

Patients with rheumatoid arthritis or psoriatic arthritis starting biologic disease-modifying antirheumatic drugs have a higher risk for interstitial lung disease vs. the general population, with the highest risk found in RA, data show.

The FDA has approved Botox Cosmetic to temporarily improve the appearance of moderate to severe platysma bands — vertical bands that connect the jaw and neck — in adults, according to a press release from the manufacturer.

ORLANDO — A speaker at the American Society for Dermatologic Surgery Annual Meeting highlighted a set of international consensus recommendations for the use of energy-based devices for acne scar treatment.

ORLANDO — Tattoos are not just for decorative purposes; they can also be used to treat vitiligo, according to a presentation at the American Society for Dermatologic Surgery Annual Meeting.

The largest retailer in the nation has sampled a taste of the autoimmune specialty pharmacy market, and has decided it wants more.

The FDA has approved 320 mg pre-filled syringes and autoinjectors of Bimzelx for the treatment of active psoriatic arthritis with coexisting moderate-to-severe plaque psoriasis, according to a press release from UCB.

A new study confirmed previous findings that acne products containing benzoyl peroxide have high levels of cancer-causing benzene which are not stabilized by encapsulation techniques even at room temperature.